Hi-Tech Licenses Rights to Extended Release Antihistamine/Decongestant for its ECR Pharmaceuticals Subsidiary

Hi-Tech Pharmacal Co., Inc. HITK announced today that they acquired marketing and distribution rights to an ANDA filing from KVK-Tech, Inc. for dexbrompheniramine maleate 6mg/pseudoephedrine sulfate 120 mg extended release tablets. The product will be marketed by ECR, Hi-Tech's branded sales and marketing company under the Lodrane® brand name. David Seltzer, Hi-Tech's President and CEO said, “We are pleased to have the near-term opportunity to introduce through ECR an extended release antihistamine/decongestant. The product is similar to our Lodrane® brand products and will allow us to leverage significant equity in the brand, particularly as approximately 500 unapproved cough/cold and allergy products will be removed from the market in September 2011.”